1101 related articles for article (PubMed ID: 22174255)
1. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.
Michaud M; Martins I; Sukkurwala AQ; Adjemian S; Ma Y; Pellegatti P; Shen S; Kepp O; Scoazec M; Mignot G; Rello-Varona S; Tailler M; Menger L; Vacchelli E; Galluzzi L; Ghiringhelli F; di Virgilio F; Zitvogel L; Kroemer G
Science; 2011 Dec; 334(6062):1573-7. PubMed ID: 22174255
[TBL] [Abstract][Full Text] [Related]
2. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.
Martins I; Michaud M; Sukkurwala AQ; Adjemian S; Ma Y; Shen S; Kepp O; Menger L; Vacchelli E; Galluzzi L; Zitvogel L; Kroemer G
Autophagy; 2012 Mar; 8(3):413-5. PubMed ID: 22361584
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.
Kepp O; Galluzzi L; Martins I; Schlemmer F; Adjemian S; Michaud M; Sukkurwala AQ; Menger L; Zitvogel L; Kroemer G
Cancer Metastasis Rev; 2011 Mar; 30(1):61-9. PubMed ID: 21249425
[TBL] [Abstract][Full Text] [Related]
4. Witch hunt against tumor cells enhanced by dendritic cells.
Locher C; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Kroemer G; Zitvogel L
Ann N Y Acad Sci; 2009 Sep; 1174():51-60. PubMed ID: 19769736
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
Aymeric L; Apetoh L; Ghiringhelli F; Tesniere A; Martins I; Kroemer G; Smyth MJ; Zitvogel L
Cancer Res; 2010 Feb; 70(3):855-8. PubMed ID: 20086177
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G
Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485
[TBL] [Abstract][Full Text] [Related]
7. Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
Fucikova J; Kralikova P; Fialova A; Brtnicky T; Rob L; Bartunkova J; Spísek R
Cancer Res; 2011 Jul; 71(14):4821-33. PubMed ID: 21602432
[TBL] [Abstract][Full Text] [Related]
8. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
[TBL] [Abstract][Full Text] [Related]
9. Autophagy as a mediator of chemotherapy-induced cell death in cancer.
Notte A; Leclere L; Michiels C
Biochem Pharmacol; 2011 Sep; 82(5):427-34. PubMed ID: 21704023
[TBL] [Abstract][Full Text] [Related]
10. Blocking the interleukin 2 (IL2)-induced systemic autophagic syndrome promotes profound antitumor effects and limits toxicity.
Lotze MT; Buchser WJ; Liang X
Autophagy; 2012 Aug; 8(8):1264-6. PubMed ID: 22660171
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
[TBL] [Abstract][Full Text] [Related]
12. [Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy].
Apetoh L; Ghiringhelli F; Zitvogel L
Med Sci (Paris); 2007 Mar; 23(3):257-8. PubMed ID: 17349284
[No Abstract] [Full Text] [Related]
13. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
14. [Antitumoral immunization during cancer chemotherapy].
Zitvogel L; Hannani D; Aymeric L; Kepp O; Martins I; Kroemer G
Bull Acad Natl Med; 2012 Jun; 196(6):1075-86. PubMed ID: 23596856
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of immunogenic cancer cell death.
Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
[TBL] [Abstract][Full Text] [Related]
16. [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy].
Kroemer G; Adjemian S; Michaud M; Martins I; Kepp O; Sukkurwala AQ; Menger L; Vacchelli E; Ma Y; Zitvogel L
Bull Mem Acad R Med Belg; 2011; 166(3-4):130-8; discussion 139-40. PubMed ID: 22375493
[TBL] [Abstract][Full Text] [Related]
17. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y
Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690
[TBL] [Abstract][Full Text] [Related]
18. Desirable cell death during anticancer chemotherapy.
Locher C; Conforti R; Aymeric L; Ma Y; Yamazaki T; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Morel Y; Girard JP; Kroemer G; Zitvogel L
Ann N Y Acad Sci; 2010 Oct; 1209():99-108. PubMed ID: 20958322
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
[TBL] [Abstract][Full Text] [Related]
20. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
